| Name | Walgreens #7126 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 4501 Grand Ave, Duluth, Minnesota 55807 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (218) 628-2897 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis.
A national research centre for bowel disease is to be set up in London to bring the Cinderella area of medicine to the forefront of surgical innovation.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 9 days ago
| NPI Number | 1861407173 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #07126 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4501 Grand Ave, Duluth, MN 55807 |
| Phone Number | 218-628-2897 |
News Archive
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis.
A national research centre for bowel disease is to be set up in London to bring the Cinderella area of medicine to the forefront of surgical innovation.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 9 days ago
News Archive
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis.
A national research centre for bowel disease is to be set up in London to bring the Cinderella area of medicine to the forefront of surgical innovation.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers.
› Verified 9 days ago
Cvs Pharmacy #06686 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4528 Grand Ave, Duluth, Minnesota 55807 Phone: (218) 624-2820 | |
Cvs Pharmacy #06691 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1215 E Superior St, Duluth, Minnesota 55802 Phone: (218) 724-3735 | |
Cvs Pharmacy #16001 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1902 Miller Trunk Hwy, Duluth, Minnesota 55811 Phone: (218) 727-8475 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 115 N 24th Ave W, Duluth, Minnesota 55806 Phone: (218) 722-2222 | |
Fairview Home Infusion Duluth Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1527 London Rd, Duluth, Minnesota 55812 Phone: (218) 730-2200 |